Xtant Begin Period Cash Flow from 2010 to 2025
| XTNT Stock | USD 0.52 0.01 1.89% |
Begin Period Cash Flow | First Reported 2008-12-31 | Previous Quarter 4.6 M | Current Value 5.5 M | Quarterly Volatility 5.6 M |
Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 53.7 M or Gross Profit of 34 M, as well as many indicators such as Price To Sales Ratio of 1.61, Dividend Yield of 0.0 or PTB Ratio of 2.86. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
Xtant | Begin Period Cash Flow |
Latest Xtant Medical's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of Xtant Medical Holdings over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Xtant Medical's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Xtant Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 7,933,801 | |
| Geometric Mean | 3,097,981 | |
| Coefficient Of Variation | 108.40 | |
| Mean Deviation | 6,938,006 | |
| Median | 4,926,066 | |
| Standard Deviation | 8,600,259 | |
| Sample Variance | 74T | |
| Range | 24.8M | |
| R-Value | 0.82 | |
| Mean Square Error | 25.4T | |
| R-Squared | 0.68 | |
| Significance | 0.000086 | |
| Slope | 1,489,138 | |
| Total Sum of Squares | 1109.5T |
Xtant Begin Period Cash Flow History
About Xtant Medical Financial Statements
Xtant Medical shareholders use historical fundamental indicators, such as Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 23.6 M | 24.8 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.